Medicare to cover PrismRA diagnostic test for certain patients with rheumatoid arthritis
Healio » Rheumatoid Arthritis
by
7M ago
Medicare will begin offering coverage for PrismRA, a molecular diagnostic test that predicts treatment response in certain patients with rheumatoid arthritis, according to a press release from its manufacturer ..read more
Visit website
Patients with RA prioritize physical function, limiting side effects when choosing therapy
Healio » Rheumatoid Arthritis
by
7M ago
New patients with rheumatoid arthritis are more likely to consider impact on physical function and the potential for adverse events when choosing therapy options, according to data published in BMC Rheumatology ..read more
Visit website
EULAR definition of difficult-to-treat rheumatoid arthritis leaves ‘some holes’
Healio » Rheumatoid Arthritis
by
7M ago
SAN DIEGO — The official EULAR definition of difficult-to-treat rheumatoid arthritis does not fully account for the problems the disease can present, according to a presenter at the Congress of Clinical Rheumatology West ..read more
Visit website
‘The elephant in the room’: Age, disease-related factors may drive JAK safety signals
Healio » Rheumatoid Arthritis
by
7M ago
SAN DIEGO — Patient age and disease-related factors may be driving safety signals in medications used to treat rheumatoid arthritis and psoriatic disease, according to a speaker at the 2023 Congress of Clinical Rheumatology West ..read more
Visit website
Medicare price negotiation list includes rheumatology drugs ustekinumab, etanercept
Healio » Rheumatoid Arthritis
by
8M ago
The first 10 drugs eligible for price negotiation through Medicare includes etanercept and ustekinumab, biologic therapies commonly used to treat patients with rheumatic diseases, the Biden administration announced ..read more
Visit website
Patients receiving TNFi for rheumatoid arthritis more likely to develop psoriasis
Healio » Rheumatoid Arthritis
by
8M ago
Patients with rheumatoid arthritis who receive TNF inhibitors are more likely to develop psoriasis vs. those treated with methotrexate, according to an analysis of more than 880,000 post-marketing reports published in Scientific Reports ..read more
Visit website
Head-to-head trial data in rheumatoid arthritis scant, offer ‘shaky evidence’
Healio » Rheumatoid Arthritis
by
8M ago
SAN DIEGO — Rheumatology research still offers too few head-to-head clinical trials of biologic medications to help clinicians manage rheumatoid arthritis, according to data presented at the 2023 Congress of Clinical Rheumatology West ..read more
Visit website
Rheumatologists must be ‘more proactive’ in response to patients losing abortion access
Healio » Rheumatoid Arthritis
by
8M ago
Following last year’s U.S. Supreme Court’s decision overturning federal abortion protections, rheumatologists must change their practice with regard managing patients’ reproductive health, said presenter at the 2023 AWIR annual conference ..read more
Visit website
Biosimilar TNF inhibitors led to reduced prices, no increase in availability in Poland
Healio » Rheumatoid Arthritis
by
8M ago
The emergence of biosimilar TNF inhibitors in Poland led to reduced prices and expenditures, but little improvements in treatment availability, according to data published in Annals of the Rheumatic Diseases ..read more
Visit website
First 10 drugs chosen for Medicare price negotiations
Healio » Rheumatoid Arthritis
by
8M ago
HHS announced the first 10 drugs that will be subject to Medicare price negotiations ..read more
Visit website

Follow Healio » Rheumatoid Arthritis on FeedSpot

Continue with Google
Continue with Apple
OR